NASDAQ:ROIV

Roivant Sciences Stock Forecast

etoro logo Buy ROIV
*Your capital is at risk
$34.07
+0.0500 (+0.147%)
At Close: Jun 26, 2026
AI Analysis AI Analysis of ROIV AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add ROIV to Watchlist?
Some Reasons Why To Add ROIV:
  • +199.1% price growth over the last year
  • High gross margin of 84.4%
  • Low bankruptcy risk (Altman Z-Score: 34.50)
PDF

Evaluation of Roivant Sciences Ltd. stock downgraded after the last trading session
(Updated on Jun 26, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy or Hold candidate since May 21, 2026 Gain 10.33%

The Roivant Sciences Ltd. stock price gained 0.147% on the last trading day (Friday, 26th Jun 2026), rising from $34.02 to $34.07. It has now gained 4 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 2.16% from a day low at $33.72 to a day high of $34.45. The price has risen in 8 of the last 10 days and is up by 14.6% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 3 million more shares were traded than the day before. In total, 12 million shares were bought and sold for approximately $422.69 million.

The stock has broken the wide and strong rising the short-term trend up and an even stronger rate of rising is indicated. For any reaction back there will now be support on the roof on the current trend broken at $33.93, a level that may pose a second chance to hit a runner. According to fan-theory $38.58 will be the next possible trend-top level and thereby pose a resistance level that may not be broken at the first attempt.

ROIV Signals & Forecast

The Roivant Sciences Ltd. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $32.60 and $30.02. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday, June 02, 2026, and so far it has risen 20.60%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.

Support, Risk & Stop-loss for Roivant Sciences Ltd. stock

Roivant Sciences Ltd. finds support from accumulated volume at $32.41 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.730 between high and low, or 2.16%. For the last week, the stock has had daily average volatility of 4.39%.

The Roivant Sciences Ltd. stock is extremely overbought on RSI14 (87). Normally this may pose a good selling opportunity but since the stock has broken the trend up, the chance for a major correction due to high RSI is very small as the stock will find support at the trend broken.

Our recommended stop-loss: $32.70 (-4.02%) (This stock has medium daily movements and this gives medium risk. The RSI14 is 87 and this increases the risk substantially. There is a buy signal from a pivot bottom found 17 days ago.)

Trading Expectations (ROIV) For The Upcoming Trading Day Of Monday 29th

For the upcoming trading day on Monday, 29th we expect Roivant Sciences Ltd. to open at $34.08, and during the day (based on 14 day Average True Range), to move between $33.49 and $34.65, which gives a possible trading interval of +/-$1.15 (+/-3.44%) up or down from last closing price. If Roivant Sciences Ltd. takes out the full calculated possible swing range there will be an estimated 3.44% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $32.41, some $1.66 (4.87%) from the current price of $34.07, our system finds the risk reward attractive.

Earnings coming up

Roivant Sciences Ltd. will release earnings BMO on Wednesday, July 01, 2026.The consensus among the analysts for the expected earnings (EPS) is -$0.308. We will update the financials statements for Roivant Sciences Ltd., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 8.22% in the first trading day after earnings release.

Is Roivant Sciences Ltd. stock A Buy?

Roivant Sciences Ltd. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Hold candidate.

Current score: 0.000 Hold/Accumulate Downgraded

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Fair Opening Price

Predicted fair opening price on June 29, 2026 - $34.08 ( 0.0294%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

ROIV Performance

Trading levels for ROIV

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 34.81 2.17%
R2 34.53 1.35%
R1 34.36 0.85%
Price 34.07
S1 33.80 -0.789%
S2 33.63 -1.29%
S3 33.35 -2.11%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 0 -
R1 0 -
Price 34.07
S1 32.41 -4.87%
S2 29.39 -13.74%
S3 28.55 -16.20%

FAQ

What is the symbol for Roivant Sciences Ltd. Stock and on which exchange is it traded?
The symbol for Roivant Sciences Ltd. is ROIV and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Roivant Sciences Ltd. Stock?
Roivant Sciences Ltd. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Hold candidate.

How to buy Roivant Sciences Ltd. Stock?
Roivant Sciences Ltd. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Roivant Sciences Ltd. Stock.

What's the current price of Roivant Sciences Ltd. Stock?
As of the end of day on the Jun 26, 2026, the price of an Roivant Sciences Ltd. (ROIV) share was $34.07.

What is the 52-week high and low for Roivant Sciences Ltd. Stock?
The 52-week high for Roivant Sciences Ltd. Stock is $34.68 and the 52-week low is $10.70.

What is the market capitalization of Roivant Sciences Ltd. Stock?
As of the Jun 26, 2026, the market capitalization of Roivant Sciences Ltd. is 24.506B.

When is the next earnings date for Roivant Sciences Ltd.?
The upcoming earnings date for Roivant Sciences Ltd. is Jul 01, 2026.
Click to get the best stock tips daily for free!
ABOUT ROIVANT SCIENCES LTD.
Roivant Sciences
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, warm autoimmune hemolytic anemia, thyroid eye diseases, sarcoidosis, and staph aur...
GOLDEN STAR
Ticker Change Signal Date
NMRK
$15.02
1.66% Jun 24
X
XMAX
$8.34
5.40% Jun 24
JLL
$299.78
5.10% Jun 24
NESR
$25.07
12.64% Jun 23
TTEK
$28.04
4.35% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE